News
Editor's Top Picks
Berkshire Hathaway Conglomerate Structure Makes Future Capital Appreciation Problematic
This article was written byFollowDavid H. Lerner is an analyst with a decade of experience utilizing his professional background in…
Your one-stop resource for personal news and tips.
More form News
Right-wing populists perform strongly in Swiss parliamentary elections
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…
United Therapeutics: Fundamental And Technical Analyses Justify A Buy Decision (UTHR)
Investment Thesis United Therapeutics Corporation (NASDAQ:UTHR) has been in a long-term uptrend since 2019, making…
Israelis queue to buy guns in aftermath of Hamas attacks
In a suburb of the Israeli city of Kefar Sava, gunshots rang out on a…
Comus Investment Q3 2023 Letter
*April 1st – Dec 31st, 2016 The compounded performance figures represent all realized and unrealized…
Ten years of China’s Belt and Road: what has $1tn achieved?
“When you give roses to others, their fragrance lingers on your hand,” Xi Jinping told…
ClearBridge Global Infrastructure Value Strategy Q3 2023 Portfolio Manager Commentary
By Charles Hamieh, Shane Hurst, Nick Langley, & Simon Ong Utilities Fundamentals Intact as Market…
Executive at WPP-owned agency detained over bribery claims
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…
Equifax: Guidance Revised But Uncertainty Remains (NYSE:EFX)
Overview My recommendation for Equifax (NYSE:EFX) is a hold rating as there is a lot…
US signals intention to engage with Niger junta
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…
Enterprise Products Partners: A Strong Second Half Expected, FCF Gains Ahead (NYSE:EPD)
High-dividend stocks have been battered on a relative basis in 2023 as rising interest rates…
Big companies defy expectations to become even bigger
Stay informed with free updatesSimply sign up to the Companies myFT Digest -- delivered directly…
Bristol-Myers Squibb Acquisition Of Mirati Makes Sense (NYSE:BMY)
Bristol-Myers Squibb (NYSE:BMY) is one of the largest pharmaceutical companies in the world with a…
Ark finds silver lining in massive ETF losses: years of tax benefits
Stay informed with free updatesSimply sign up to the Exchange traded funds myFT Digest --…
AngloGold Ashanti: Good Growth Prospect (NYSE:AU)
Part I: Introduction Johannesburg-based AngloGold Ashanti Limited (NYSE:AU) released its H1 2023 results ending June…
Diplomacy faces four tough challenges on Israel and Gaza
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…